Guy Young/LinkedIn;
Mark T. Reding/emedevents.com/
Mar 12, 2026, 11:50
Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
Guy Young, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, shared a post on LinkedIn:
“I’m looking forward to speaking at THSNA 2026 on Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery.
Join Mark T. Reding, MD and I as we discuss:
- Clarifying the role of gene therapy in hemophilia B within an evolving treatment landscape
- Improving patient selection and counseling in real-world practice
- Operationalizing delivery – from referral coordination to infusion management, monitoring, and long-term follow-up across care settings
This symposium will take place live in person on March 21 at 6:45 AM PDT at the Oregon Convention Center in Portland during the THSNA 2026 Annual Meeting, with a live virtual program to follow on March 30 at 7:00 PM EDT.
Other posts featuring Guy Young on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda